trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['lung', 'destiny,lung02', 'astrazeneca']
today, we presented #latebreaking data from the destiny-lung02 phase ii trial in her2-mutant metastatic non-small cell #lungcancer at #esmo22. learn more here: 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.